What Dr John had to say, page-6

I believe that Dr. Greenwood is continuing to use the CCS terminology, and I can’t see any substantial difference between the NovoSkin CCS and the CCS mentioned within Dr. Greenwood’s Skin Tissue Engineering venture. (See Dr. Greenwood’s linkdin profile)

I am certain that what has happened is that PolyNovo is concentrating on its core business and is leaving bioreactors etc. to Dr. Greenwood. I expect that there will be a significant level of coordination and cooperation between PolyNovo and Skin T.E. as I believe that Dr. Greenwood will continue to use a NovoSorb scaffold.

In short, while there may have been a rejiggering of the relationship between Dr. Greenwood and PolyNovo with respect to the CCS, I don’t think the CCS itself has changed much, although it could be subject to continuous improvement.